Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) EPS (Weighted Average and Diluted) (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with $0.06 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 127.27% year-over-year to $0.06, compared with a TTM value of $0.34 through Sep 2025, up 145.27%, and an annual FY2024 reading of -$0.06, up 92.57% over the prior year.
  • EPS (Weighted Average and Diluted) was $0.06 for Q3 2025 at Aveanna Healthcare Holdings, down from $0.13 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.15 in Q4 2024 and bottomed at -$3.62 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.36, with a median of $0.02 recorded in 2021.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 1200.0% in 2022, while the deepest fall reached 25700.0% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then crashed by 36300.0% to -$3.62 in 2022, then skyrocketed by 92.71% to -$0.26 in 2023, then skyrocketed by 157.33% to $0.15 in 2024, then plummeted by 60.34% to $0.06 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for AVAH at $0.06 in Q3 2025, $0.13 in Q2 2025, and $0.03 in Q1 2025.